![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
MJ Miller, H Sadowska-Krowicka, S Chotinaruemol, JL Kakkis and DA Clark
Department of Pediatrics, Louisiana State University School of Medicine, New Orleans.
Nitric oxide synthesis appears to be elevated in inflammatory bowel disease, but little is known about the contribution of nitric oxide to the pathophysiological process. To address this issue, we included the nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (L- NAME) in the drinking water (10 or 100 micrograms/ml) of guinea pigs immediately after induction of ileitis by intraluminal trinitrobenzenesulfonic acid (TNBS 30 mg/kg in 50% ethanol). Guinea pigs were sacrificed after 7 days of this ad libitum treatment. Control groups received either intraluminal TNBS, saline or ethanol (TNBS vehicle) without L-NAME or TNBS + D-NAME (100 micrograms/ml), the inactive enantiomer. Immediately before sacrifice, guinea pigs were anesthetized and saline was administered intraluminally at the site of TNBS or saline administration and then withdrawn after 30 min. Change in lavage volume and lavage protein and nitrite levels were measured, as well as tissue myeloperoxidase and bowel wall thickness (weight/length). TNBS administration resulted in an increase in tissue thickness, myeloperoxidase and lavage protein and nitrite levels over sham controls. Oral L-NAME prevented these responses. D-NAME was ineffective with the exception of tissue thickness. The change in intestinal lavage fluid volume indicated that reabsorptive processes dominated in the sham and TNBS + L-NAME groups, and secretory responses predominated in TNBS and TNBS + D-NAME animals. In contrast to TNBS- induced ileitis, L-NAME (100 micrograms/ml, p.o., 7 days) administration to intact animals resulted in a local inflammatory response (i.e., increased myeloperoxidase activity and a fluid secretory response).(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
|
|
 |
|
  H.-S. Huang, M.-C. Ma, and J. Chen Chronic L-arginine administration increases oxidative and nitrosative stress in rat hyperoxaluric kidneys and excessive crystal deposition Am J Physiol Renal Physiol, August 1, 2008; 295(2): F388 - F396. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. O'Hara, W. Ho, D. R. Linden, G. M. Mawe, and K. A. Sharkey Enteroendocrine cells and 5-HT availability are altered in mucosa of guinea pigs with TNBS ileitis Am J Physiol Gastrointest Liver Physiol, November 1, 2004; 287(5): G998 - G1007. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Vallance, G. Dijkstra, B. Qiu, L. A. van der Waaij, H. van Goor, P. L. M. Jansen, H. Mashimo, and S. M. Collins Relative contributions of NOS isoforms during experimental colitis: endothelial-derived NOS maintains mucosal integrity Am J Physiol Gastrointest Liver Physiol, October 1, 2004; 287(4): G865 - G874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-S. Cho and C. Chae Expression of Cyclooxygenase-2 and Nitric Oxide Synthase 2 in Swine Ulcerative Colitis Caused by Salmonella typhimurium Vet. Pathol., July 1, 2004; 41(4): 419 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Potoka, J. S. Upperman, X.-R. Zhang, J. R. Kaplan, S. J. Corey, A. Grishin, R. Zamora, and H. R. Ford Peroxynitrite inhibits enterocyte proliferation and modulates Src kinase activity in vitro Am J Physiol Gastrointest Liver Physiol, November 1, 2003; 285(5): G861 - G869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.-W. Chen, J.-S. Wang, B. Hwang, J.-S. Chen, and C.-M. Hsu Reversal of the Effect of Albumin on Gut Barrier Function in Burn by the Inhibition of Inducible Isoform of Nitric Oxide Synthase Arch Surg, November 1, 2003; 138(11): 1219 - 1225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Gyurko, G. Boustany, P. L. Huang, A. Kantarci, T. E. Van Dyke, C. A. Genco, and F. C. Gibson III Mice Lacking Inducible Nitric Oxide Synthase Demonstrate Impaired Killing of Porphyromonas gingivalis Infect. Immun., September 1, 2003; 71(9): 4917 - 4924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Yadav, Z. Liu, and M. M. Rafi A Diarylheptanoid from Lesser Galangal (Alpinia officinarum) Inhibits Proinflammatory Mediators via Inhibition of Mitogen-Activated Protein Kinase, p44/42, and Transcription Factor Nuclear Factor-{kappa}B J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 925 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Rodriguez-Cabezas, J. Galvez, M. D. Lorente, A. Concha, D. Camuesco, S. Azzouz, A. Osuna, L. Redondo, and A. Zarzuelo Dietary Fiber Down-Regulates Colonic Tumor Necrosis Factor {alpha} and Nitric Oxide Production in Trinitrobenzenesulfonic Acid-Induced Colitic Rats J. Nutr., November 1, 2002; 132(11): 3263 - 3271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Gill, S. Saksena, I. A. Syed, S. Tyagi, W. A. Alrefai, J. Malakooti, K. Ramaswamy, and P. K. Dudeja Regulation of NHE3 by nitric oxide in Caco-2 cells Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G747 - G756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-H. Lo, Y.-C. Liang, S.-Y. Lin-Shiau, C.-T. Ho, and J.-K. Lin Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-{kappa}B in mouse macrophages Carcinogenesis, June 1, 2002; 23(6): 983 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Miceli, G. P. Morris, W. K. MacNaughton, and S. Vanner Alterations in capsaicin-evoked electrolyte transport during the evolution of guinea pig TNBS ileitis Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G972 - G980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Yue, P.-S. Lai, K. Yin, F. F. Sun, R. G. Nagele, X. Liu, K. K. Linask, C. Wang, K.-T. Lin, and P. Y-K. Wong Colon Epithelial Cell Death in 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis Is Associated with Increased Inducible Nitric-Oxide Synthase Expression and Peroxynitrite Production J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 915 - 925. [Abstract] [Full Text]
|
|
|
|
|
|
D.-M. McCafferty, E. Sihota, M. Muscara, J. L. Wallace, K. A. Sharkey, and P. Kubes Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G90 - G99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Cohavy, D. Bruckner, L. K. Gordon, R. Misra, B. Wei, M. E. Eggena, S. R. Targan, and J. Braun Colonic Bacteria Express an Ulcerative Colitis pANCA-Related Protein Epitope Infect. Immun., March 1, 2000; 68(3): 1542 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D M McCAFFERTY Peroxynitrite and inflammatory bowel disease Gut, March 1, 2000; 46(3): 436 - 439. [Full Text] [PDF]
|
|
|
|
|
|
D-M McCafferty, M Miampamba, E Sihota, K A Sharkey, and P Kubes Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice Gut, December 1, 1999; 45(6): 864 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Forte, R S Dykhuizen, E Milne, A McKenzie, C C Smith, and N Benjamin Nitric oxide synthesis in patients with infective gastroenteritis Gut, September 1, 1999; 45(3): 355 - 361. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kawachi, A. Cockrell, F. S. Laroux, L. Gray, D. N. Granger, H. C. van der Heyde, and M. B. Grisham Role of inducible nitric oxide synthase in the regulation of VCAM-1 expression in gut inflammation Am J Physiol Gastrointest Liver Physiol, September 1, 1999; 277(3): G572 - G576. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B Zingarelli, C Szabo, and A L Salzman Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase Gut, August 1, 1999; 45(2): 199 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. S. Miller and M. Sandoval III. A molecular prelude to intestinal inflammation Am J Physiol Gastrointest Liver Physiol, April 1, 1999; 276(4): G795 - G799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E Holt and R. Bajoria The role of nitro-reduction and nitric oxide in the toxicity of chloramphenicol Human and Experimental Toxicology, February 1, 1999; 18(2): 111 - 118. [Abstract] [PDF]
|
|
|
|
|
|
F H MOURAD, J L TURVILL, and M J G FARTHING Role of nitric oxide in intestinal water and electrolyte transport Gut, February 1, 1999; 44(2): 143 - 147. [Full Text] [PDF]
|
|
|
|
|
|
B. Zingarelli, S. Cuzzocrea, C. Szabó, and A. L. Salzman Mercaptoethylguanidine, a Combined Inhibitor of Nitric Oxide Synthase and Peroxynitrite Scavenger, Reduces Trinitrobenzene Sulfonic Acid-Induced Colonic Damage in Rats J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1048 - 1055. [Abstract] [Full Text]
|
|
|
|
|
|
O Jeanneton, M Delvaux, Y Langlois, P Le Bars, J Le Bars, M B Delisle, J Frexinos, and L Bueno Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig Gut, September 1, 1998; 43(3): 356 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Birder, G. Apodaca, W. C. De Groat, and A. J. Kanai Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder Am J Physiol Renal Physiol, August 1, 1998; 275(2): F226 - F229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Fletcher, W. R. Widmer, S. Luell, A. Christen, C. Orevillo, S. Shah, and D. Visco Therapeutic Administration of a Selective Inhibitor of Nitric Oxide Synthase Does Not Ameliorate the Chronic Inflammation and Tissue Damage Associated with Adjuvant-Induced Arthritis in Rats J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 714 - 721. [Abstract] [Full Text]
|
|
|
|
|
|
S. Aiko, J. Fuseler, and M. B. Grisham Effects of Nitric Oxide Synthase Inhibition or Sulfasalazine on the Spontaneous Colitis Observed in HLA-B27 Transgenic Rats J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 722 - 727. [Abstract] [Full Text]
|
|
|
|
|
|
H Kimura, R Hokari, S Miura, T Shigematsu, M Hirokawa, Y Akiba, I Kurose, H Higuchi, H Fujimori, Y Tsuzuki, et al. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis Gut, February 1, 1998; 42(2): 180 - 187. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. F. Kuemmerle Synergistic regulation of NOS II expression by IL-1beta and TNF-alpha in cultured rat colonic smooth muscle cells Am J Physiol Gastrointest Liver Physiol, January 1, 1998; 274(1): G178 - G185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Rachmilewitz, E Okon, and F Karmeli Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn's disease Gut, September 1, 1997; 41(3): 358 - 365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Conner, S. Brand, J. M. Davis, F. S. Laroux, V. J. Palombella, J. W. Fuseler, D. Y. Kang, R. E. Wolf, and M. B. Grisham Proteasome Inhibition Attenuates Nitric Oxide Synthase Expression, VCAM-1 Transcription and the Development of Chronic Colitis J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1615 - 1622. [Abstract] [Full Text]
|
|
|
|
|
|
K. A. Ribbons, M. G. Currie, J. R. Connor, P. T. Manning, P. C. Allen, P. Didier, M. S. Ratterree, D. A. Clark, and M. J. S. Miller The Effect of Inhibitors of Inducible Nitric Oxide Synthase on Chronic Colitis in the Rhesus Monkey J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 1008 - 1015. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Moncada and A. Higgs The L-Arginine-Nitric Oxide Pathway N. Engl. J. Med., December 30, 1993; 329(27): 2002 - 2012. [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
